1. Atypical teratoid/rhabdoid tumor in adults: a systematic review of the literature with meta-analysis and additional reports of 4 cases

   • Giuseppe Broggi
   • Francesca Gianno
   • Manila Antonelli

   Topic Review 25 February 2022 Pages: 1 - 14

   

2. Recycling of SLC38A1 to the plasma membrane by DSCR3 promotes acquired temozolomide resistance in glioblastoma

   • Rui Lin
   • Yimin Xu
   • Yawei Liu

   Laboratory Investigation 21 February 2022 Pages: 15 - 26

   

3. Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study

   • Daniel Antunes Moreno
   • Luciane Sussuchi da Silva
   • Rui Manuel Reis

   Laboratory Investigation 15 February 2022 Pages: 27 - 35

   

4. Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies

   • Denise Obrecht
   • Martin Mynarek
   • Stefan Rutkowski

   Clinical Study Open access 21 February 2022 Pages: 37 - 48

   

5. Eigenvector PageRank difference as a measure to reveal topological characteristics of the brain connectome for neurosurgery

   • Onur Tanglay
   • Isabella M. Young
   • Michael E. Sughrue

   Clinical Study 04 February 2022 Pages: 49 - 61

   

6. Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases

   • Oz Haim
   • Shani Abramov
   • Rachel Grossman

   Clinical Study 04 February 2022 Pages: 63 - 69

   

7. Postoperative epilepsy and survival in glioma patients: a nationwide population-based cohort study from 2009 to 2018

   • Mirketa Marku
   • Birthe Krogh Rasmussen
   • Pernille Envold Bidstrup

   Clinical Study 28 January 2022 Pages: 71 - 80

   

8. Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases

   • Maria Diaz
   • Priya Singh
   • Elena Pentsova

   Clinical Study 03 February 2022 Pages: 81 - 90

   

9. Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience

   • Bryan J. Neth
   • Samantha N. Balakrishnan
   • Michael W. Ruff

   Clinical Study 25 January 2022 Pages: 91 - 100

   

10. Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases

    • Mohammed Abdulhaleem
    • Hannah Johnston
    • Michael D. Chan

    Clinical Study 15 February 2022 Pages: 101 - 107

    

11. Frameless robot-assisted stereotactic biopsies for lesions of the brainstem—a series of 103 consecutive biopsies

    • Iulia Peciu-Florianu
    • Victor Legrand
    • Nicolas Reyns

    Clinical Study 27 January 2022 Pages: 109 - 119

    

12. Stereotactic radiosurgery versus active surveillance for incidental, convexity meningiomas: a matched cohort analysis from the IMPASSE study

    • Stylianos Pikis
    • Georgios Mantziaris
    • Jason Sheehan

    Clinical Study 29 January 2022 Pages: 121 - 128

    

13. Effects of sleep disturbance on neuropsychological functioning in patients with pediatric brain tumor

    • Jenna A. Chiang
    • Paulina T. Feghali
    • Ashley M. Whitaker

    Clinical Study 29 January 2022 Pages: 129 - 135

    

14. Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma

    • Waqar Haque
    • Caitlyn Teh
    • Bin S. Teh

    Clinical Study 01 February 2022 Pages: 137 - 146

    

15. Clinical and molecular characteristics of pediatric low-grade glioma complicated with ventriculo-peritoneal shunt related ascites

    • Palma Solano-Páez
    • Adriana Fonseca
    • Eric Bouffet

    Clinical Study 05 February 2022 Pages: 147 - 156

    

16. Postoperative CT scans after resection of brain metastases: neurosurgical routine or added value?

    • Kaiyun Yang
    • Alexander P. Landry
    • Paul N. Kongkham

    Clinical Study 29 January 2022 Pages: 157 - 163

    

17. Predictors of hearing functional outcome following surgery for cerebellopontine angle meningioma

    • Nida Fatima
    • Anne K. Maxwell
    • Gregory P. Lekovic

    Clinical Study 03 February 2022 Pages: 165 - 176

    

18. The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study

    • Andres Ramos-Fresnedo
    • Michael W. Pullen
    • Wendy J. Sherman

    Clinical Study 17 February 2022 Pages: 177 - 185

    

19. Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review

    • Dayton Grogan
    • David P. Bray
    • Kimberly B. Hoang

    Clinical Study 25 February 2022 Pages: 187 - 195

    

20. Trends in radiation dose for low grade gliomas across the United States

    • Emma Byrne
    • Stephen Abel
    • Rodney E. Wegner

    Clinical Study 23 February 2022 Pages: 197 - 205